Financials Elkem ASA

Equities

ELK

NO0010816093

Specialty Chemicals

Market Closed - Oslo Bors 10:45:00 2024-04-26 EDT 5-day change 1st Jan Change
19.92 NOK +2.63% Intraday chart for Elkem ASA +3.00% -5.86%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,393 16,498 18,833 22,334 13,413 12,628 - -
Enterprise Value (EV) 1 20,386 24,556 23,660 24,949 22,863 22,708 20,887 21,014
P/E ratio 16.8 x 69.2 x 4.01 x 2.34 x 192 x 25.2 x 5.97 x 4.59 x
Yield 2.42% 0.53% 10.1% 17% - 1.52% 6.85% 7.84%
Capitalization / Revenue 0.63 x 0.67 x 0.56 x 0.49 x 0.38 x 0.36 x 0.32 x 0.29 x
EV / Revenue 0.9 x 0.99 x 0.7 x 0.54 x 0.64 x 0.65 x 0.53 x 0.49 x
EV / EBITDA 7.68 x 9.15 x 3.04 x 1.94 x 6.06 x 5.6 x 3.71 x 3.27 x
EV / FCF -67.5 x -273 x 13.3 x 4.75 x -12.4 x 31.4 x 15.1 x 19.3 x
FCF Yield -1.48% -0.37% 7.54% 21.1% -8.09% 3.19% 6.62% 5.19%
Price to Book 1.12 x 1.32 x 0.95 x 0.78 x 0.55 x 0.51 x 0.47 x 0.45 x
Nbr of stocks (in thousands) 581,310 581,310 631,546 634,477 633,890 633,940 - -
Reference price 2 24.76 28.38 29.82 35.20 21.16 19.92 19.92 19.92
Announcement Date 20-02-13 21-02-10 22-02-09 23-02-08 24-02-08 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 22,668 24,691 33,717 45,898 35,545 34,822 39,714 42,981
EBITDA 1 2,656 2,684 7,791 12,887 3,771 4,052 5,637 6,419
EBIT 1 1,260 913 5,899 12,414 1,682 1,516 3,124 3,805
Operating Margin 5.56% 3.7% 17.5% 27.05% 4.73% 4.35% 7.87% 8.85%
Earnings before Tax (EBT) 1 1,134 584 5,827 12,236 951 934.5 2,784 3,620
Net income 1 855 239 4,628 9,561 72 502.1 2,117 2,751
Net margin 3.77% 0.97% 13.73% 20.83% 0.2% 1.44% 5.33% 6.4%
EPS 2 1.470 0.4100 7.440 15.04 0.1100 0.7920 3.335 4.336
Free Cash Flow 1 -302 -90 1,785 5,256 -1,850 724 1,384 1,090
FCF margin -1.33% -0.36% 5.29% 11.45% -5.2% 2.08% 3.48% 2.54%
FCF Conversion (EBITDA) - - 22.91% 40.79% - 17.87% 24.54% 16.98%
FCF Conversion (Net income) - - 38.57% 54.97% - 144.2% 65.35% 39.62%
Dividend per Share 2 0.6000 0.1500 3.000 6.000 - 0.3025 1.365 1.561
Announcement Date 20-02-13 21-02-10 22-02-09 23-02-08 24-02-08 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 10,397 11,876 12,326 11,293 10,404 9,654 9,258 7,917 8,436 7,961 8,446 8,998 9,875 9,508 10,197
EBITDA 1 3,059 3,875 3,924 3,302 1,787 1,565 1,039 535 632 721 1,006 1,147 1,291 1,195 1,221
EBIT 1 2,586 3,400 3,428 3,879 1,397 1,520 469 -217 -73 114 388.7 512.6 655.5 580 605
Operating Margin 24.87% 28.63% 27.81% 34.35% 13.43% 15.74% 5.07% -2.74% -0.87% 1.43% 4.6% 5.7% 6.64% 6.1% 5.93%
Earnings before Tax (EBT) 1 2,538 3,401 3,773 3,884 1,178 1,385 255 -338 -351 -311 296 407.9 475.6 443.8 543.6
Net income 1 1,964 2,658 2,962 3,046 894 952 36 -456 -461 -439 222.5 309.3 357.3 337.2 414.5
Net margin 18.89% 22.38% 24.03% 26.97% 8.59% 9.86% 0.39% -5.76% -5.46% -5.51% 2.63% 3.44% 3.62% 3.55% 4.07%
EPS 2 3.100 4.180 4.650 4.790 1.410 1.490 0.0600 -0.7200 -0.7300 -0.6900 0.2396 0.4680 0.7493 0.5701 0.7826
Dividend per Share 2 3.000 - - - 6.000 - - - - - - - 0.4000 - -
Announcement Date 22-02-09 22-04-27 22-07-19 22-10-26 23-02-08 23-04-28 23-07-14 23-10-25 24-02-08 24-04-18 - - - - -
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,993 8,058 4,827 2,615 9,450 10,080 8,259 8,386
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.256 x 3.002 x 0.6196 x 0.2029 x 2.506 x 2.487 x 1.465 x 1.306 x
Free Cash Flow 1 -302 -90 1,785 5,256 -1,850 724 1,384 1,090
ROE (net income / shareholders' equity) 6.46% 1.88% 28.6% 39.5% 0.27% 1.8% 7.34% 8.97%
ROA (Net income/ Total Assets) 2.84% 0.8% 12.7% 20.2% 0.17% 2.35% 4.54% 6.15%
Assets 1 30,066 29,946 36,369 47,315 41,860 21,365 46,602 44,741
Book Value Per Share 2 22.10 21.60 31.30 45.10 38.30 39.30 42.50 44.10
Cash Flow per Share - - - - - - - -
Capex 1 2,141 2,201 3,128 4,058 4,856 2,858 2,424 2,904
Capex / Sales 9.45% 8.91% 9.28% 8.84% 13.66% 8.21% 6.1% 6.76%
Announcement Date 20-02-13 21-02-10 22-02-09 23-02-08 24-02-08 - - -
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
19.92 NOK
Average target price
25.6 NOK
Spread / Average Target
+28.51%
Consensus